Yan Leyfman, Internal Medicine and Clinical Researcher at Icahn School of Medicine at Mount Sinai, shared a post on LinkedIn:
“Honored to have been invited to be a Speaker at the 2024 Technology Networks the landscape of Cancer Research Conference to discuss the promise of cell therapies to treat severe SARS-COV-2 in cancer patients. Thank you to the organizers for the invitation. I would also like to acknowledge the hard work of our research team and am grateful to Chandler Park and Sharma for their great mentorship.”
